康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03759 康龙化成

交易中 05-05 10:08:46

20.240

-0.940

-4.44%

最高21.180	最低20.200	成交量36.27万
今开21.180	昨收21.180	日振幅4.63%
总市值370.39亿	流通市值71.45亿	总股本18.30亿
成交额740.31万	换手率0.10%	流通股本3.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03759","market":"HK","secType":"STK","nameCN":"康龙化成","latestPrice":20.24,"timestamp":1777946911116,"preClose":21.18,"halted":0,"volume":362700,"delay":0,"changeRate":-0.044381491973560026,"floatShares":353000000,"shares":1830000000,"eps":1.0769931503521983,"marketStatus":"交易中","change":-0.94,"latestTime":"05-05 10:08:46","open":21.18,"high":21.18,"low":20.2,"amount":7403082,"amplitude":0.04627,"askPrice":20.24,"askSize":7000,"bidPrice":20.22,"bidSize":1900,"shortable":3,"etf":0,"ttmEps":1.0886688889341598,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1777953600000},"marketStatusCode":2,"adr":0,"listingDate":1574870400000,"exchange":"SEHK","adjPreClose":21.18,"dividendRate":0.010809,"openAndCloseTimeList":[[1777944600000,1777953600000],[1777957200000,1777968000000]],"volumeRatio":0.3678,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":29.31,"timestamp":1777532400000,"preClose":29.75,"halted":0,"volume":36564400,"delay":0,"premium":"-39.77"}},"requestUrl":"/m/hq/s/03759","defaultTab":"news","newsList":[{"id":"2632693585","title":"【机构调研记录】富安达基金调研康龙化成、帝奥微等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2632693585","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632693585?lang=zh_cn&edition=full","pubTime":"2026-05-01 08:02","pubTimestamp":1777593765,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月30日披露的机构调研信息，富安达基金近期对4家上市公司进行了调研，相关名单如下：1）康龙化成 调研纪要：一季度实验室服务新签订单同比增长超20%，小分子CDMO同比增长超50%，主要由临床后期大规模生产订单带动。2）帝奥微 调研纪要：2025年，公司实现营业收入56,203.90万元，同比增长6.80%，毛利率为42.86%。受晶圆及封装成本上涨影响，公司或将调整产品价格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100008189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688381","300759","BK0216","BK0214","03759","BK1141","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631863523","title":"康龙化成最新公告：股东拟合计减持不超1.5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2631863523","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631863523?lang=zh_cn&edition=full","pubTime":"2026-04-30 19:01","pubTimestamp":1777546906,"startTime":"0","endTime":"0","summary":"康龙化成(300759.SZ)公告称，持股5%以上股东信中康成及其一致行动人信中龙成计划自公告披露之日起15个交易日后的3个月内，以集中竞价、大宗交易等方式减持公司股份合计不超过27,559,200股(占公司总股本的1.50%)。减持原因为创业投资基金股东存续期限即将到期及自身资金需求。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000061943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","300759","03759","BK1141","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631686139","title":"康龙化成：小分子CDMO一季度订单加速增长来自两方面因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2631686139","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631686139?lang=zh_cn&edition=full","pubTime":"2026-04-30 16:30","pubTimestamp":1777537800,"startTime":"0","endTime":"0","summary":"证券日报网4月30日讯，康龙化成在接受调研者提问时表示，小分子CDMO一季度订单加速增长来自两方面因素，分别是项目数量增加、项目进入中后期后带来的订单金额提升，其中FollowMolecule项目从早期进入后期带来的订单额放大是核心的贡献因素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604303726489341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","CDMO","BK1141","300759","03759","BK4139","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631597403","title":"康龙化成(03759)获楼小强质押1100万股和解除质押1100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631597403","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631597403?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:52","pubTimestamp":1777459954,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)发布公告，康龙化成(北京)新药技术股份有限公司(以下简称“公司”)近日接到公司实际控制人之一楼小强先生的函告，获悉楼小强先生将其所持有的公司部分股份进行了质押1100万股股份和解除质押1100万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436383.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","BK1141","300759","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106539712","title":"异动解读 | 康龙化成盘中大跌5.22%，一季度现金流与毛利率下滑引担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1106539712","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106539712?lang=zh_cn&edition=full","pubTime":"2026-04-29 09:40","pubTimestamp":1777426808,"startTime":"0","endTime":"0","summary":"康龙化成(03759)今日盘中股价大幅下挫5.22%，引发市场关注。消息面上，公司于近期发布了2026年第一季度业绩报告。报告显示，尽管公司营业收入和归母净利润同比有所增长，但部分关键财务指标出现下滑。其中，经营活动产生的现金流量净额同比大幅下降29.13%，毛利率较去年同期减少1.16个百分点，净资产收益率(ROE)也略有下降。此外，公司存货周转率同比下降15.26%。这些数据可能引发了投资者对公司盈利质量和运营效率的担忧。此前，公司股价在业绩发布前一个交易日曾因资金流入而上涨，但今日开盘后市场对一季报细节的消化导致了股价的显著回调。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630301916","title":"康龙化成(03759)：郑北获提名为执行董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2630301916","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630301916?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:07","pubTimestamp":1777378032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)发布公告，根据公司的董事提名政策，(i)楼柏良博士、楼小强先生及郑北女士获公司股东提名为执行董事候选人;(ii)万璇女士获股东提名为非执行董事候选人;及(iii)独立非执行董事候选人李丽华女士、曾劲峰教授及沈蓉女士，由董事会提名委员会推荐，并由董事会提名。根据公司章程，第三届董事会的任期为三年。任期届满后，李家庆先生与余坚先生将不再参与第四届董事会选举。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","BK1576","300759","BK0216","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158034900","title":"康龙化成2026年第一季度营收35.78亿元，经调整净利润4.06亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158034900","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158034900?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:50","pubTimestamp":1777369822,"startTime":"0","endTime":"0","summary":"康龙化成公布截至2026年3月31日止第一季度业绩，营业收入约35.78亿元，同比增长15.48%。经调整净利润约4.06亿元，同比增长16.25%。报告期内经营活动产生的现金流量净额约6.04亿元，同比下降29.13%。从成本结构看，销售费用增长至约0.78亿元，同比增长约13%，管理费用约4.42亿元，同比增长约11%，公司研发投入约1.40亿元，占收入比仍保持在较高水平，同比增长约14%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康龙化成2026年第一季度营收35.78亿元，经调整净利润4.06亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630374103","title":"康龙化成(03759)一季度归母净利润3.35亿元 同比增长9.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630374103","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630374103?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:43","pubTimestamp":1777369435,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康龙化成(03759)发布2026年第一季度业绩，营业收入35.78亿元，同比增长15.48%;归属于上市公司股东的净利润3.35亿元，同比增长9.75%;每股基本盈利0.186元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174237942","title":"康龙化成2025年营收同比增14.8%至140.95亿元，多业务协同保持全球布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1174237942","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174237942?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:29","pubTimestamp":1777368559,"startTime":"0","endTime":"0","summary":"康龙化成公布截至2025年12月31日止年度主要经营数据，报告期内实现收入140.95亿元人民币，较2024年度的122.76亿元人民币增长14.8%，主要得益于全球业务的稳健拓展与一体化服务平台的协同效应。若扣除非经常性损益影响，母公司拥有人应占经调整净利润为18.16亿元人民币，同比增长13.0%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康龙化成2025年营收同比增14.8%至140.95亿元，多业务协同保持全球布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630376613","title":"4月28日康龙化成涨5.42%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630376613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630376613?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:34","pubTimestamp":1777365267,"startTime":"0","endTime":"0","summary":"证券之星消息，4月28日康龙化成涨5.42%，收盘报30.92元，换手率4.1%，成交量58.15万手，成交额17.93亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共69家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.7908，较上一交易日下跌0.22%，近一年上涨14.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800049306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","159760","BK1576","BK1141","03759","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629043267","title":"小摩减持康龙化成(03759)约60.51万股 每股作价约21.39港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629043267","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629043267?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:20","pubTimestamp":1776856826,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月17日，小摩减持康龙化成(03759)60.5052万股，每股作价21.3947港元，总金额约为1294.49万港元。减持后最新持股数目约为2104.76万股，最新持股比例为5.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BYXW3230.USD","EWH","IE00BHPRN162.USD","LU0943347566.SGD","LU0320765646.SGD","LU2242649171.HKD","IE00BDCRKT87.USD","LU0868494617.USD","IE00B775SV38.USD","LU0149725797.USD","LU0256863902.USD","LU0345769631.USD","BK4566","LU1548497426.USD","LU1267930490.SGD","IE00B3S45H60.SGD","LU0208291251.USD","LU2552382132.HKD","IE00BKDWB100.SGD","LU0310799852.SGD","300759","LU1670627923.USD","LU1988902786.USD","SG9999002224.SGD","LU0170899867.USD","IE00BBT3K403.USD","LU1084165304.USD","BK0216","LU0265550359.USD","IE00B1BXHZ80.USD","LU2505996681.GBP","LU0820562030.AUD","IE00BJLML261.HKD","JPO","03759","LU1363072403.SGD","IE00BWXC8680.SGD","LU1280957306.USD","LU1496350502.SGD","LU2106854487.HKD","LU2746668461.USD","LU2237443382.USD","LU0689472784.USD","LU2023250504.SGD","LU2237443978.SGD","LU1914381329.SGD","IE0034235188.USD","LU0320765489.SGD","JPMO","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628221164","title":"港股异动 | CXO 概念股跌幅居前 海外投融资大环境进入波动阶段 AI制药或导致研发及临床端分化","url":"https://stock-news.laohu8.com/highlight/detail?id=2628221164","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628221164?lang=zh_cn&edition=full","pubTime":"2026-04-17 11:31","pubTimestamp":1776396664,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CXO概念股跌幅居前，截至发稿，昭衍新药跌5.82%，报21.7港元；康龙化成跌3.65%，报21.1港元；泰格医药跌3.02%，报42.46港元。中信建投发布研报称，海外投融资大环境进入季度间波动，不同阶段、不同疾病领域的CXO服务需求进一步分化，国内投融资活动景气度持续上行，弹性更强，持续看好CXO板块成长空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK4585","VXUS","AGIX","03759","CHAT","01477","BK1574","BK1583","CXO","AIPO","BK4588","03347","ARTY","06127","BK1576","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627341513","title":"大摩：微升康龙化成(03759)目标价至31.5港元 评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2627341513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627341513?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:00","pubTimestamp":1776153636,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，更新康龙化成(03759)的风险回报; 目标价由31港元上调至31.5港元，评级“增持”。该行因应集团2025年业绩，将2026至2030年的盈利预测上调低于1%至3%，以反映收入预期提高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","300759","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624668291","title":"康龙化成（300759）披露截至2026年3月31日证券变动月报表，4月3日股价下跌1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624668291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624668291?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:04","pubTimestamp":1775225061,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，康龙化成报收于30.07元，较前一交易日下跌1.8%，最新总市值为552.47亿元。近日，康龙化成（北京）新药技术股份有限公司发布截至2026年3月31日的证券变动月报表。H股总数为359,977,887股，其中已发行股份352,714,587股，库存股7,263,300股；A股总数为1,477,305,741股，无库存股。库存H股已指定用于2025年H股奖励信托计划。此外，存在两项A股限制性股票激励计划及一项H股奖励信托计划，但2026年3月未发生新增股份发行或库存股转让。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300043101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","BK1576","300759","161027","BK0216","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107561402","title":"康龙化成更新3月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1107561402","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107561402?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:47","pubTimestamp":1775119678,"startTime":"0","endTime":"0","summary":"康龙化成（北京）新药技术股份有限公司于2026年4月2日披露了3月股份变动月报表。报告期为2026年3月1日至3月31日，整体股本结构保持稳定，未见新增发行或回购注销活动。报告显示，本月底公司法定注册股本为人民币18.37亿元。H股库存部分未发生转让或注销变动，公司此前回购的7,263,300股H股仍持作为激励计划使用。公告还显示，公司确认遵守香港联合交易所有限公司《上市规则》的相关规定，截至3月末，公司股本总数保持不变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624540176","title":"智通港股早知道 | 美国执行载人绕月任务火箭发射升空 国际能源署署长：4月石油供应缺口将达到3月的两倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2624540176","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624540176?lang=zh_cn&edition=full","pubTime":"2026-04-02 07:33","pubTimestamp":1775086385,"startTime":"0","endTime":"0","summary":"美国执行载人绕月任务火箭发射升空当地时间4月1日傍晚，美国航空航天局新一代登月火箭“太空发射系统”从佛罗里达州肯尼迪航天中心发射升空，执行“阿耳忒弥斯2号”载人绕月任务。这是美国自1972年以来首次载人飞向月球。据知情人士透露，这家卫星制造与火箭发射公司已以保密方式递交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","XOP","02256","300750","BK1116","BK1576","688796","BK4570","LU1807302812.USD","LU0067412154.USD","LU0880133367.SGD","300759","03750","02315","LU1152091754.HKD","BK1194","BK1600","LU1993786604.SGD","BK1610","06681","03759","LU1152091168.USD","01857","BK1191","XLE","BK1515","BK4588","LU1960683339.HKD","00460","BK4585","BK1141","LU1008478684.HKD","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624299599","title":"康龙化成：制剂商业化车间投产获国际大药企订单 小分子CDMO毛利率有望提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2624299599","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624299599?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:16","pubTimestamp":1775034962,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月1日，康龙化成(300759.SZ)发布投资者关系活动记录表公告，公司位于北京第二园区的制剂商业化生产车间建设完成，并于2026年第一季度与一家国际大型制药公司签订战略合作协议，为其首个注册申报的口服小分子GLP-1受体激动剂提供商业化生产服务。报告期内，公司新签订单金额同比增长超过14%，新增客户超过950家，活跃客户超过3,300家。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604013691983183.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604013691983183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","BK0216","300759","CDMO","BK1141","BK4139","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179410696","title":"异动解读 | 康龙化成盘中大涨11.69%，2025年第四季度净利润同比增40.76%获机构看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1179410696","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179410696?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:26","pubTimestamp":1775032016,"startTime":"0","endTime":"0","summary":"康龙化成今日盘中大涨11.69%，引起了市场的广泛关注。消息面上，公司2025年度业绩显示，尽管全年母公司拥有人应占利润同比下降7.2%，但单看第四季度表现强劲，公司单季度主营收入40.09亿元，同比上升15.93%；归母净利润5.23亿元，同比大幅上升40.76%。报告期内，公司实验室服务实现营业收入81.589亿元，同比增长15.8%，2025年度实现毛利率44.7%。此外，公司客户询单量持续向好，2025年新签订单金额同比增长超14%，且较前三季度进一步提速。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595838","title":"4月1日康龙化成涨8.58%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595838?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:18","pubTimestamp":1775031483,"startTime":"0","endTime":"0","summary":"证券之星消息，4月1日康龙化成涨8.58%，收盘报30.38元，换手率5.61%，成交量79.73万手，成交额23.55亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共62家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为138.43亿元，最新净值1.7698，较上一交易日上涨0.64%，近一年上涨10.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","159760","BK1576","BK1141","03759","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595386","title":"康龙化成涨8.58%，招银国际二个月前给出“买入”评级，目标价38.08元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595386?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:17","pubTimestamp":1775031476,"startTime":"0","endTime":"0","summary":"今日康龙化成涨8.58%，收盘报30.38元。2026年1月23日，招银国际研究员黄本晨,武煜发布了对康龙化成的研报《具备加速增长潜力的一体化CXO》，该研报对康龙化成给出“买入”评级，认为其目标价为38.08元，现价距离目标价尚有25.35%的涨幅空间。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为77.5%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为民生证券的孙建、郭双喜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","300759"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pharmaron.com","stockEarnings":[{"period":"1week","weight":0.0282},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0537},{"period":"6month","weight":-0.1369},{"period":"1year","weight":0.4841},{"period":"ytd","weight":0.0812}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":0.039},{"period":"3month","weight":-0.0275},{"period":"6month","weight":0.0062},{"period":"1year","weight":0.1596},{"period":"ytd","weight":0.0182}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康龙化成（北京）新药技术股份有限公司是一家主要从事医药研发的中国公司。该公司运营五个分部。实验室服务分部主要包括实验室化学和生物科学服务，服务项目涵盖小分子化学药、寡核苷酸、多肽、抗体、抗体偶联药物和细胞与基因治疗产品等。化学和制剂工艺开发及生产服务分部包括原料药工艺开发及生产以及预制剂、制剂开发。临床研究服务分部包括国外临床研究服务和国内临床研究服务。大分子和细胞与基因治疗服务分部包括大分子药物发现及开发与生产服务和细胞与基因治疗实验室及基因治疗药物开发与生产服务。该公司还通过其他分部开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.020001},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.03401},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.039469},{"month":4,"riseRate":0.857143,"avgChangeRate":0.052264},{"month":5,"riseRate":0.714286,"avgChangeRate":0.018171},{"month":6,"riseRate":0.666667,"avgChangeRate":0.075892},{"month":7,"riseRate":0.666667,"avgChangeRate":0.081227},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.032342},{"month":9,"riseRate":0.666667,"avgChangeRate":0.134004},{"month":10,"riseRate":0.5,"avgChangeRate":-0.053116},{"month":11,"riseRate":0.333333,"avgChangeRate":0.03614},{"month":12,"riseRate":0.571429,"avgChangeRate":0.025859}],"exchange":"SEHK","name":"康龙化成","nameEN":"PHARMARON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,03759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}